Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForesight Technology Regulatory News (FTV)

Share Price Information for Foresight Technology (FTV)

Share Price is delayed by 15 minutes
Get Live Data
64.50    1.50 (2.33%)
Bid:
63.00
Ask:
66.00
Spread: 3.00 (4.762%)
Market Cap: £231.20m
FTV Live PriceLast checked at - London Stock Exchange

Intraday Foresight Technology Share Chart

Foresight VCT plc - Increase in Offer Shares

21 Apr 2020 12:26



Foresight VCT plc - Increase in Offer Shares

FORESIGHT VCT PLC (Company)

Increase in Offer Shares

The Company issued a prospectus dated 28 January 2020 (Prospectus) relating to an offer for subscription to raise up to £20 million, with an over-allotment facility to raise up to a further £5 million (Offer), through the issue of ordinary shares of 1p each in the capital of the Company (Offer Shares). The Company announced utilisation of the over-allotment facility on 13 March 2020.

The Company announces an increase to the maximum number of Offer Shares available under the Offer from 32.5 million to 34.5 million (Increase). The increase is to accommodate the additional number of Offer Shares required to raise the aggregate amount of £25 million originally sought under the Offer as a result of Offer Shares being issued at the lower NAV per Share announced on 27 March 2020, which reflected valuation reductions generally across the investments in the portfolio as a result of the market volatility arising from the impact of the Coronavirus (Covid-19) pandemic affecting all businesses including those in which the Company invests.

For further information please contact:

Company Secretary

Foresight Group LLP

Contact: Gary Fraser Tel: 0203 667 8100

Investor Relations

Foresight Group LLP

Contact: Ellie Kakoulli Tel: 0203 667 8181


Date   Source Headline
5th Jun 202612:30 pmBUSResult of AGM
4th Jun 20264:30 pmBUSBoard Changes
4th Jun 20261:25 pmBUSNet Asset Value(s)
29th May 20264:30 pmBUSTotal Voting Rights
30th Apr 20264:30 pmBUSTotal Voting Rights
30th Apr 202610:00 amBUSTransaction in Own Shares
14th Apr 20263:15 pmBUSFinal Results
1st Apr 20267:00 amBUSTotal Voting Rights
20th Mar 20264:08 pmBUSIssue of Equity
6th Mar 202611:31 amBUSIssue of Equity
27th Feb 20264:30 pmGNWTotal Voting Rights
20th Feb 20267:05 amGNWDirector/PDMR Shareholding
20th Feb 20267:00 amGNWIssue of Equity
6th Feb 20263:56 pmGNWDirector/PDMR Shareholding
6th Feb 20263:54 pmGNWIssue of Equity
4th Feb 202610:55 amGNWOFFER FOR SUBSCRIPTION - UPDATE
30th Jan 20264:30 pmGNWTotal Voting Rights
14th Jan 20262:26 pmGNWPublication of a Prospectus - CORRECTION
14th Jan 202612:39 pmGNWPublication of a Prospectus
31st Dec 202512:00 pmBUSTotal Voting Rights
31st Dec 202512:00 pmRNSTotal Voting Rights
31st Dec 202512:00 pmGNWTotal Voting Rights
18th Dec 20254:10 pmRNSTransaction in Own Shares
18th Dec 20254:10 pmGNWTransaction in Own Shares
4th Dec 20253:40 pmGNWNet Asset Value(s)
28th Nov 20255:25 pmGNWTotal Voting Rights
31st Oct 20253:53 pmGNWAppointment of Non-Executive Director
31st Oct 202512:30 pmGNWTotal Voting Rights
17th Oct 202512:23 pmGNWTransaction in Own Shares
30th Sep 20254:30 pmGNWTotal voting rights
25th Sep 20254:13 pmGNWHalf-year report
29th Aug 20254:30 pmGNWTotal voting rights
27th Aug 20254:59 pmGNWDirector/PDMR Shareholding
31st Jul 20254:24 pmGNWTotal voting rights
21st Jul 20257:00 amGNWIntention to Fundraise
1st Jul 20257:05 amGNWTotal voting rights
1st Jul 20257:00 amGNWTransaction in Own Shares
30th Jun 20254:11 pmGNWIssue of Equity
19th Jun 202512:30 pmGNWCorrection: Net Asset Value(s)
17th Jun 20253:41 pmGNWNet Asset Value(s)
16th Jun 20254:30 pmGNWDividend Declaration
2nd Jun 20254:14 pmGNWAGM Statement
2nd Jun 20251:56 pmGNWNet Asset Value(s)
30th May 20254:30 pmGNWTotal voting rights
13th May 202510:39 amGNWTransaction in Own Shares
12th May 20257:00 amGNWIssue of Equity
12th May 20257:00 amGNWDirector/PDMR Shareholding
30th Apr 20254:30 pmGNWTotal voting rights
16th Apr 202511:32 amGNWFinal Results
10th Apr 20254:18 pmGNWIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.